-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Northwest Biotherapeutics Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2023.
- Northwest Biotherapeutics Inc Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$19.4M, a 17.6% increase year-over-year.
- Northwest Biotherapeutics Inc Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$69.5M, a 9.61% increase year-over-year.
- Northwest Biotherapeutics Inc annual Net Income (Loss) Attributable to Parent for 2023 was -$62.6M, a 40.4% increase from 2022.
- Northwest Biotherapeutics Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$105M, a 159% decline from 2021.
- Northwest Biotherapeutics Inc annual Net Income (Loss) Attributable to Parent for 2021 was $179M.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)